病程修飾抗風濕病藥物及生物製劑對妊娠預後及受影響兒童健康的衝擊---一個全國性群體研究

Medicine and Dentistry

1. Adverse Drug Reaction 14%
2. Adverse Event 14%
3. Adverse Outcome 14%
4. Antirheumatic Agent 100%
5. B Cell 14%
6. Behavioral Change 14%
7. Biological Product 100%
8. Chemicals and Drugs 14%
9. Child Health 14%
10. Childbirth 28%
11. Childhood Disease 14%
12. Conception 14%
13. Congenital Disorder 14%
14. Dermatomyositis 14%
15. Disease 14%
16. Disease Exacerbation 14%
17. Disease Modifying Antirheumatic Drug 100%
18. Drug Exposure 14%
19. Drug Therapy 14%
20. Fetus Development 14%
21. First Trimester Pregnancy 14%
22. Glucocorticoid 14%
23. Hydroxychloroquine 14%
24. Immune Function 14%
25. Infection 14%
26. Inflammatory Arthritis 7%
27. Intrauterine Growth Retardation 14%
28. Lactation 14%
29. Medicine 14%
30. Neonates 14%
31. Nerve Cell Differentiation 14%
32. Nonsteroid Antiinflammatory Agent 14%
33. Population Research 100%
34. Pregnancy 14%
35. Premature Labor 14%
36. Prematurity 14%
37. Rheumatic Disease 85%
38. Rheumatoid Arthritis 14%
39. Salazosulfapyridine 14%
40. Sjoegren Syndrome 14%
41. Spondylarthritis 14%
42. Symptom 7%
43. Systemic Lupus Erythematosus 14%
44. Systemic Scleroderma 14%
45. Teratogenicity 14%

Pharmacology, Toxicology and Pharmaceutical Science

1. Adverse Drug Reaction 14%
2. Adverse Event 14%
3. Adverse Outcome 14%
4. Antirheumatic Agent 100%
5. Biological Product 100%
6. Chemicals and Drugs 14%
7. Childhood Disease 14%
8. Congenital Disorder 14%
9. Dermatomyositis 14%
10. Disease 14%
11. Disease Exacerbation 14%
12. Disease Modifying Antirheumatic Drug 100%
13. Glucocorticoid 14%
14. Hydroxychloroquine 14%
15. Infection 14%
16. Inflammatory Arthritis 7%
17. Intrauterine Growth Retardation 14%
18. Non-Steroidal Anti-Inflammatory Drug 14%
19. Population Study 100%
20. Premature Labor 14%
21. Prematurity 14%
22. Rheumatic Disease 85%
23. Rheumatoid Arthritis 14%
24. Sjoegren Syndrome 14%
25. Spondylarthritis 14%
26. Sulfasalazine 14%
27. Symptom 7%
28. Systemic Lupus Erythematosus 14%
29. Systemic Sclerosis 14%
30. Teratogenicity 14%